Callan JMB Inc. (CJMB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Callan JMB Inc.

    NASDAQ: CJMB · Real-Time Price · USD
    5.02
    0.42 (9.07%)
    At close: Sep 10, 2025, 3:58 PM

    Callan JMB Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Cash & Equivalents
    		 2.1M 5.16M 6.19M
    Short-Term Investments
    		 n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 3.65K 3.65K 3.65K
    Receivables
    		 647.96K 2.9M 7.85M
    Inventory
    		 158.36K 114.74K 79.44K
    Other Current Assets
    		 414.92K 282.96K 246.16K
    Total Current Assets
    		 3.32M 8.45M 14.37M
    Property-Plant & Equipment
    		 1.76M 1.25M 877.86K
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 1.76M 1.25M 881.51K
    Total Assets
    		 5.08M 9.71M 15.25M
    Account Payables
    		 878.04K 313.95K 667.63K
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 n/a 115.88K 110.29K
    Other Current Liabilities
    		 100.7K 171.11K 161K
    Total Current Liabilities
    		 1.28M 769.71K 1.11M
    Long-Term Debt
    		 n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a 8.07K n/a
    Total Long-Term Liabilities
    		 628.27K 140.56K 129.25K
    Total Liabilities
    		 1.91M 910.27K 1.24M
    Total Debt
    		 907.45K 400K 410.88K
    Common Stock
    		 3K 8.8M 14.01M
    Retained Earnings
    		 -2.29M n/a n/a
    Comprehensive Income
    		 n/a n/a n/a
    Shareholders Equity
    		 3.17M 8.8M 14.01M
    Total Investments
    		 n/a n/a n/a

    Add to Watchlist